Table 2.
Outcomes of FLR hypertrophy rate, morbidity and mortality in each included study
| Authors |
FLR hypertrophy |
Morbidity |
Mortality |
|||
| ALPPS | p-ALPPS | ALPPS | p-ALPPS | ALPPS | p-ALPPS | |
| Alvarez et al[10] | 107% (12.2) | 90% (20.8) | 8 (9) | 8 (21) | 1 (9) | 1 (21) |
| Chan et al[5] | - | - | 1 (13) | 3 (12) | 0 (13) | 2 (12) |
| Linecker et al[11] | 61% (15) | 64.5% (12.1) | 8 (22) | 3 (23) | 7 (22) | 0 (23) |
| Petrowsky et al[4] | - | - | 12 (18) | 2 (6) | 4 (18) | 0 (6) |
FLR: Future liver remnant; ALPPS: Associating liver partition and portal vein ligation for staged hepatectomy; p-ALPPS: Partial split of the liver parenchyma in ALPPS.